- Home
- TXRH vs PCVX Comparison
TXRH vs PCVX Comparison
Compare TXRH & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXRH
- PCVX
- Stock Information
- Founded
- TXRH 1993
- PCVX 2013
- Country
- TXRH United States
- PCVX United States
- Employees
- TXRH N/A
- PCVX N/A
- Industry
- TXRH Restaurants
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- TXRH Consumer Discretionary
- PCVX Health Care
- Exchange
- TXRH Nasdaq
- PCVX Nasdaq
- Market Cap
- TXRH 12.2B
- PCVX 11.5B
- IPO Year
- TXRH 2004
- PCVX 2020
- Fundamental
- Price
- TXRH $169.13
- PCVX $79.74
- Analyst Decision
- TXRH Buy
- PCVX Strong Buy
- Analyst Count
- TXRH 24
- PCVX 8
- Target Price
- TXRH $191.30
- PCVX $127.71
- AVG Volume (30 Days)
- TXRH 1.2M
- PCVX 913.0K
- Earning Date
- TXRH 02-20-2025
- PCVX 02-25-2025
- Dividend Yield
- TXRH 1.44%
- PCVX N/A
- EPS Growth
- TXRH 42.51
- PCVX N/A
- EPS
- TXRH 6.47
- PCVX N/A
- Revenue
- TXRH $5,373,332,000.00
- PCVX N/A
- Revenue This Year
- TXRH $17.75
- PCVX N/A
- Revenue Next Year
- TXRH $9.48
- PCVX N/A
- P/E Ratio
- TXRH $26.14
- PCVX N/A
- Revenue Growth
- TXRH 16.01
- PCVX N/A
- 52 Week Low
- TXRH $146.75
- PCVX $58.10
- 52 Week High
- TXRH $206.04
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- TXRH 36.48
- PCVX 36.96
- Support Level
- TXRH $168.18
- PCVX $82.03
- Resistance Level
- TXRH $177.55
- PCVX $84.10
- Average True Range (ATR)
- TXRH 4.44
- PCVX 3.12
- MACD
- TXRH -0.41
- PCVX -0.70
- Stochastic Oscillator
- TXRH 9.79
- PCVX 1.88
About TXRH Texas Roadhouse Inc.
Texas Roadhouse Inc is a restaurant company operating predominately in the casual dining segment. The company's operating segment includes Texas Roadhouse; Bubba's 33 and others. It generates maximum revenue from the Texas Roadhouse segment.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.